You must be AHPRA accredited Pharmacist to view this content or place an online order!

If you have completed our form and received a confirmation of your access please sign-in to your account to view.

Otherwise, and if you are a AHPRA accredited pharmacists, please complete our Pharmacist Access Application form for access. 

FAQ

Ozempic® may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. 
  • Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use Ozempic® if:
  • you or any of your family have ever had MTC or if you have MEN 2.
  • you are allergic to semaglutide or any of the ingredients in Ozempic®. See symptoms of serious allergic reaction in “What are the possible side effects of Ozempic®?”.


Before using Ozempic®, tell your health care provider if you have any other medical conditions, including if you:

  • have or have had problems with your pancreas or kidneys. 
  • have a history of diabetic retinopathy.
  • are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Ozempic® will harm your unborn baby or passes into your breast milk. You should stop using Ozempic® 2 months before you plan to become pregnant.

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.

Ozempic® may cause serious side effects, including:

  • inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®.
  • low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.
  • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • serious allergic reactions. Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • gallbladder problems. Gallbladder problems have happened in some people who take Ozempic®. Tell your health care provider right away if you get symptoms which may include: pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.

The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.

Please click here Consumer Medicine Information (CMI) summary,  Prescribing Information and Medication Guide for Ozempic®.

For detailed product information, services, and resources to support your practice click here.

Between or 2°C to 8°C.

For users: After the first use, you can store your pen at room temperature (between 15ºC to 30ºC) or continue keeping it in the refrigerator. Dispose of the pen after 56 days, regardless of whether it was stored in the refrigerator or at room temperature, even if there is medicine left in it. Do not use the Ozempic pen if it has been frozen. Avoid keeping your pens in the car, as they may get too hot or too cold.

Ozempic® (semaglutide) injection 0.25 mg or 0.5 mg is an injectable prescription medicine used:

  • along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
  • to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease.

Using Ozempic® (Semaglutide) may cause mild-to-moderate digestive discomforts such as nausea, vomiting, and diarrhea, which are typically temporary. Some people may also experience local reactions at the injection site, such as redness, swelling, or itching, and in rare instances, allergic responses. Other common side effects include reflux, abdominal pain, and fatigue.

In some patient groups, Ozempic® (Semaglutide) may increase the incidence of retinopathy (eye disease) complications.

It is important to be aware of the potential side effects of Ozempic® (Semaglutide) and to consult with your doctor if you experience any of these side effects.

Click here for medicines shortage notice

Cole supplies has TGA authorisation distribute Ozempic.  See below for links to relevant TGA documentation.

OZEMPIC semaglutide 0.25mg solution for injection pre-filled
pen: https://www.tga.gov.au/resources/section-19a-approvals/ozempic-semaglutide-025mg-solution-injection-pre-filled-pen-germany-0

OZEMPIC semaglutide 0.5mg solution for injection pre-filled pen: https://www.tga.gov.au/resources/section-19a-approvals/ozempic-semaglutide-05mg-solution-injection-pre-filled-pen-germany

These Section 19A Ozempic products are registered and marketed in Germany by Novo Nordisk A/S, so all the original labelling is in German. However, for your convenience, both Section 19A Ozempic products will be over-labelled in English. The Ozempic stock is sourced from Germany and is being distributed in Australia to alleviate the national shortage.